Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Brain Imaging01:14

Brain Imaging

898
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
898
Dementia01:30

Dementia

672
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
672
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of UK national health databases for detecting intra-cranial aneurysm rupture in the Risk of Aneurysm Rupture (ROAR) study.

PLOS digital health·2026
Same author

Age-adjusted neurofilament light chain cutoffs for diagnosing neurodegenerative dementia: a two-threshold machine learning approach.

GeroScience·2026
Same author

Correction: Urbano et al. Comparison of Serum and Cerebrospinal Fluid Neurofilament Light Chain Concentrations Measured by Ella™ and Lumipulse™ in Patients with Cognitive Impairment. <i>Diagnostics</i> 2024, <i>14</i>, 2408.

Diagnostics (Basel, Switzerland)·2026
Same author

Understanding mechanisms of voluntary engagement of mental effort using active inference.

Cognitive, affective & behavioral neuroscience·2026
Same author

Cardiac Structure Relates to Hemorrhagic Cerebral Small Vessel Disease Phenotype.

Journal of the American Heart Association·2026
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Related Experiment Video

Updated: Mar 24, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.1K

Brain imaging in dementia.

Guendalina Bonifacio1, Giovanna Zamboni1

  • 1Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, UK Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, Italy.

Postgraduate Medical Journal
|March 3, 2016
PubMed
Summary

Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) scans enhance dementia diagnosis. These brain imaging techniques reveal specific findings for frequent dementia disorders, aiding clinical characterization and research.

More Related Videos

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.4K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.4K

Related Experiment Videos

Last Updated: Mar 24, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.1K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.4K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.4K

Area of Science:

  • Neurology
  • Radiology
  • Neuroimaging

Background:

  • Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) have revolutionized the understanding of dementia syndromes.
  • These neuroimaging modalities are increasingly vital for clinical characterization and differential diagnosis of cognitive disorders.

Purpose of the Study:

  • To review specific findings from MRI and PET in common dementia disorders.
  • To highlight the role of neuroimaging in understanding dementia's impact on brain function, spatial distribution, and natural history.

Main Methods:

  • Review of established findings from various MRI techniques (e.g., structural, functional).
  • Review of established findings from PET imaging (e.g., FDG-PET, amyloid PET).
  • Correlation of imaging findings with clinical presentations of frequent dementia syndromes.

Main Results:

  • Specific patterns of brain changes identified by MRI and PET are characteristic of different dementia types.
  • Neuroimaging provides insights into disease progression, spatial patterns, and functional capacity alterations.
  • Brain imaging serves as a crucial tool in clinical trials for patient selection and outcome assessment.

Conclusions:

  • MRI and PET offer valuable, specific diagnostic information for differentiating dementia syndromes.
  • Neuroimaging is essential for advancing dementia research, clinical trials, and patient management.
  • A comprehensive understanding of imaging findings aids in diagnosing and tracking the evolution of dementia disorders.